Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018

NEW YORK, Feb. 18, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018

http://www.reportlinker.com/p01098832/Intraocular-Lens-IOL-Market-Shares-Strategies-and-Forecasts-Worldwide-Nanotechnology-2013-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Ophthalmic_Devices

Cataracts are a clouding of the eye's natural lens that impairs one's ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting.

Intraocular lens market driving forces include the aging of the population. With age, all people have cataracts which can be cured with IOL. There is an ever-increasing baby boom aging population. There is a growing precision of cataract surgery. Safety of cataract surgical medical devices and lenses are primary market concerns. More advanced procedures are driving an increase in cataract surgery. Lower costs per surgery are driving an increase in cataract surgery.

Cataract surgical technology is evolving rapidly. Premium intraocular lenses (IOLs) introduced during the past decade and those still in the pipeline are raising patient's post-cataract visual expectations. Laser-assisted cataract surgery technology is gaining traction with clinicians.

Surgeons are getting trained in the techniques needed to perform surgeries these new types of equipment. The motivation to learn the new surgical techniques is that the equipment comes with the promise of improved surgical precision.

According to Susan Eustis, lead author of the WinterGreen Research team that prepared the Intraocular Lens (IOL) market research study, "Superior image quality brings clinical improvement. Patients are thrilled when they can see so much more clearly."

As a result, growing needs and expectations for good vision in all ranges have created significant new market opportunities, expanding demand for multifocal and accommodating IOLs designed to correct presbyopia, aspheric optics that address spherical aberration and make vision sharper, and phakic IOLs allowing treatment of extreme refractive error.

Ultrasonic phacoemulsification, the standard of care in cataract removal equipment for four decades, has been in great part responsible for the safety and effectiveness of modern cataract surgery. It is certain to remain the dominant lens removal technology in the near term. A technology still in its infancy, laser-assisted cataract surgery using femtosecond lasers and picosecond lasers, promises to raise the standard of precision and safety to new heights.

Numerous types, and styles of Intraocular Lenses (IOLs), varying in size, and attachment mechanisms. The femtosecond lasers may evolve capability to fix the cataract without implanting an IOL devices, creating a significant change in the market after the forecast period.

The eye care industry is highly competitive and subject to rapid technological change and evolving industry requirements and standards. Companies within this industry compete on technological leadership and innovation, quality and efficacy of their products, relationships with eye care professionals and healthcare providers, breadth and depth of product offering and pricing. The presence of these factors varies across regions.

In the United States, the leading market segment, an aging population, the affluence of the American "baby boomer" generation, and the ability of surgeons to bill for a premium refractive outcome will drive significant growth in this lens-based refractive surgery sector.

Intraocular Lens (IOL) markets are driven by the trend towards multi-distance vision capability, near middle, and far. The global market is expected to post a modest growth. The global market for Intraocular Lenses (IOL) total market value is expected to reach $3.8 billion by 2019.

The global intraocular lens cataract market is expanding with the aging of a more affluent middle class population. There were 19 million cataract surgeries in 2010 and 19.7 million in 2012. Cataracts account for 48% of world blindness. Cataracts are the leading cause of reversible blindness.

Table of Contents

Intraocular Lens Market Driving Forces ES-1 Cataract Surgical Technology Is Evolving Rapidly ES-3 Patient Populations Have Significant Demand for Cataract Surgery ES-4 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved ES-5 Cataract Surgery Business ES-5 Intraocular Lens Market Challenges ES-6 World Population Growth ES-6 Intraocular Lens Market Shares ES-7 Intraocular Lens Market Forecasts ES-9

1. INTRAOCULAR LENS - MARKET DESCRIPTION AND MARKET DYNAMICS 1-1

1.1 Cataract Surgical Technology Is Evolving Rapidly 1-1 1.1.1 Patient Populations Have Significant Demand for Cataract Surgery 1-2 1.1.2 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved 1-4 1.1.3 Cataract Surgery Business 1-4 1.1.4 Intraocular Lens Market Challenges 1-6 1.2 World Economy Undergoing A Transformation 1-7 1.2.1 Global Economic Conditions: 1-7 1.2.2 Global Economy Becomes Steadily More Sluggish 1-9 1.2.3 Global Economic Conditions Impact Markets 1-11

2. INTRAOCULAR LENS - MARKET SHARES AND FORECASTS 2-1

2.1 Intraocular Lens Market Driving Forces 2-1 2.1.1 Cataract Surgical Technology Is Evolving Rapidly 2-3 2.1.2 Patient Populations Have Significant Demand for Cataract Surgery 2-4 2.1.3 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved 2-5 2.1.4 Cataract Surgery Business 2-5 2.1.5 Intraocular Lens Market Challenges 2-6 2.1.6 World Population Growth 2-6 2.2 Intraocular Lens Market Shares 2-7 2.2.1 Novartis / Alcon 2-10 2.2.2 Novartis / Alcon Competitive Situation 2-10 2.2.3 Novartis / Alcon Competition 2-10 2.2.4 Novartis Alcon Multifocal Lenses 2-11 2.2.5 Novartis / Alcon 2-12 2.2.6 Novartis / Alcon 2-13 2.2.7 Novartis / Alcon AcrySof Toric Intraocular Lens - (IOL) – FDA Approval P930014/S045 2-13 2.2.8 LenSx Acquired by Alcon 2-16 2.2.9 Abbott Medical Optics 2-17 2.2.10 Abbott Medical Optics / Visiogen's Synchrony 2-17 2.2.11 Abbott Tecnis 2-18 2.2.12 Abbott TECNIS IOLs 2-18 2.2.13 Bausch & Lomb Presbyopic IOLs 2-19 2.2.14 Bausch + Lomb 2-19 2.2.15 Bausch + Lomb Eye Surgical Technologies In The Pipeline 2-20 2.2.16 Bausch + Lomb: Accommodating IOLs 2-21 2.2.17 Bausch + Lomb: Crystalens IOL 2-22 2.2.18 OptiMedica 2-22 2.2.19 Staar Acrylic IOL 2-23 2.2.20 Staar 2-23 2.2.21 Staar Silicone IOLs 2-24 2.2.22 Staar Surgical Company nanoFLEX IOL 2-24 2.2.23 Staar Visian 2-25 2.2.24 LensAR 2-25 2.2.25 PhysIOL's FineVision 2-26 2.2.26 IOL Research and New Lenses 2-26 2.2.27 ReSTOR Multifocal Toric AcrySof IQ 2-27 2.2.28 Abbott Tecnis One-Piece Toric 2-29 2.2.29 Lenstec Tetraflex 2-29 2.2.30 Calhoun Vision Light-Adjustable Lens 2-30 2.2.31 Abbott Visiogen Synchrony 2-31 2.2.32 Rayner M-flex T 2-32 2.2.33 NuLens DynaCurv 2-33 2.2.34 Carl Zeiss AcriLisa Diffractive Multifocal Toric 2-33 2.2.35 Bausch + Lomb's Crystalens Toric 2-34 2.2.36 Hoya's Adoptics 2-34 2.3 Intraocular Lens Market Forecasts 2-35 2.3.1 Intraocular Lens Market Segment Forecasts 2-37 2.3.2 Number of Cataract Surgeries Per Year 2-40 2.3.3 Novartis Positioning with Sales and Marketing Resource 2-42 2.3.4 Bausch + Lomb Small Incisions 2-44 2.3.5 Femtosecond Technology Is Game Changer 2-44 2.3.6 Intraocular Lens Unit Analysis 2-46 2.3.7 Aspheric Foldable IOL Lens 2-46 2.3.8 Intraocular Lens Presbyopia Market Forecasts 2-48 2.3.9 Market Trend: Monofocal IOL Channel Will Be Slowly But Continuously Eroded By The Multifocal IOL 2-49 2.3.10 Presbyopia-Correcting Intraocular Lens (IOL) 2-49 2.3.11 Premium Channel Surgeons 2-49 2.3.12 Market Trend: Accommodating IOL Channel to Grow 2-51 2.3.13 Market Trends: Diffractive Lenses 2-52 2.3.14 Market Trend: Multifocal IOLs 2-52 2.3.15 Market Trend: Surgical Workstation 2-53 2.3.16 Premium IOL Forecasts 2-53 2.3.17 Technologies Driving Intraocular Lens IOL Market Growth 2-54 2.3.18 Diffractive IOLs 2-55 2.3.19 Large Middleclass Population Base Driving Intraocular Lens IOL Market Growth 2-55 2.3.20 Nonfoldable Polymethylmethacrylate/Plexiglas Based Lenses To Silicone And Acrylic Based Foldable Lenses 2-56 2.3.21 Global Vision Care and Ocular Market 2-56 2.4 Intraocular Lens Prices 2-57 2.4.1 Premium Lens Technology Reimbursement Trends 2-57 2.4.2 CMS Medicare Intorocular Reimbursement Guidelines 2-57 2.5 Intraocular Lens Regional Market 2-58 2.5.1 Eye Surgical Techniques by Country 2-62 2.5.2 United States 2-65 2.5.3 Canada 2-65 2.5.4 Brazil Cataract Surgical Procedure 2-67 2.5.5 Brazilian Cataract surgeries 2-68 2.5.6 China 2-68 2.5.7 Toric Lens Implantations On The Rise In Europe 2-68 2.5.8 Advanced Technology Intraocular Lens Growth Markets 2-69 2.5.9 Cataract Surgery in the UK 2-70 2.5.10 Asia-Pacific Cataract Surgery 2-70 2.5.11 Cataract Surgery in India 2-71 2.5.12 Cataract Surgery Assembly Line System Followed At Aravind Eye Hospitals 2-73 2.5.13 Aurolab's Low-Cost, High-Volume Business Model 2-74 2.5.14 Highly Efficient Operations Coupled With Pricing Structure Allow 50% Profit Margin 2-74 2.5.15 World Health Organization (WHO), 2-75

3. INTRAOCULAR LENS (IOL) - PRODUCT DESCRIPTION 3-1

3.1 IOL lenses 3-1 3.2 Novartis / Alcon 3-2 2.1.1 Novartis / Alcon 3-2 2.1.2 Novartis / Alcon Competitive Situation 3-3 2.1.3 Novartis / Alcon Competition 3-3 2.1.4 Novartis Alcon Multifocal Lenses 3-4 2.1.5 Novartis / Alcon 3-5 2.1.6 Novartis / Alcon 3-6 2.1.7 Novartis / Alcon AcrySof Toric Intraocular Lens - (IOL) – FDA Approval P930014/S045 3-6 2.1.8 LenSx Acquired by Alcon 3-8 3.3 Abbott Medical Optics / Visiogen's Synchrony 3-9 3.3.1 Abbott Medical Optics Synchrony 3-11 3.3.2 Abbott Medical Optics' 3-12 3.3.3 Abbott Medical Optics / Visiogen's Synchrony Lens 3-12 3.4 Bausch & Lomb / Crystalens 3-17 3.4.1 Bausch & Lomb Crystalens AO Lens 3-18 3.4.2 Bausch + Lomb: Accommodating IOLs 3-18 3.4.3 Bausch + Lomb: Crystalens IOL 3-19 3.4.4 Bausch & Lomb Crystalens HD 3-22 3.5 Calhoun Vision's Light Adjustable Lens 3-23 3.6 NuLens 3-23 3.7 PixelOptics 3-23 3.8 Imperial Medical Technologies' 3-23 3.9 Presbia's Flexivue 3-23 3.10 Lenstec's Tetraflex Lens 3-23 3.11 Staar 3-24 3.11.1 STAAR Surgical Company nanoFLEX IOL 3-25 3.11.2 Staar Elastimide Silicone Aspheric IOL 3-29 3.11.3 Staar nanoFLEX Collamer Aspheric Single-Piece IOL 3-29 3.11.4 Staar Afinity Collamer Aspheric IOL 3-29 3.11.5 STAAR Toric IOL 3-30 3.11.6 Staar Afinity and nanoFLEX Collamer Aspheric IOLs 3-32 3.11.7 Staar Collamer Advantage 3-32 3.11.8 Staar nanoFLEX Collamer Aspheric Single-Piece IOL 3-36 3.11.9 STAAR Surgical Elastimide Silicone Aspheric IOL Model AQ2015A 3-37 3.11.10 STAAR Elastimide Lens Model AQ2003V 3-40 3.11.11 STAAR Elastimide Lens Model AQ2010V 3-41 3.11.12 STAAR Elastimide Lens Model AQ5010V - Low Diopter 3-42 3.11.13 STAAR Elastimide Lens Model AQ2017V (Discontinued) 3-44 3.11.14 STAAR Elastimide Lens Model AQ1016V (Discontinued) 3-45 3.11.15 STAAR Elastic Lens Model AA4204VF 3-46 3.11.16 STAAR Elastic Lens Model AA4204VL 3-47 3.11.17 STAAR Elastic Lens Model AA4207VF (Discontinued) 3-48 3.11.18 STAAR Toric Silicone Single Piece IOL 3-49 3.11.19 STAAR Elastic Toric Lens Model AA4203TL 3-56 3.11.20 Canon-STAAR Preloaded IOL Model KS-3Ai 3-57 3.12 Lxenstec's Tetraflex 3-58 3.12.1 Lxenstec's Tetraflex Manufactured To A Tenth Of A Diopter Toleranc3-e 59 3.12.2 Lxenstec Elenza Lens 3-60 3.13 Hoya 3-60 3.14 Tecnis MF 3-62 3.14.1 PowerVision (Belmont, Calif.), Oculentis (Berlin), and PhysIOL (Liège, Belgium 63 3.14.2 PowerVision's FluidVision 3-63 3.14.3 FluidVision 3-64 3.15 MPlus by Oculentis 3-64 3.16 PhysIOL's FineVision 3-65 3.17 WaveTec Vision 3-66 3.18 Pediatric Cataract / Intraocular Lenses (IOL) 3-66 3.18.1 4 D change in power is needed between ages 10 and 20 3-69 3.18.2 Correcting Astigmatism in Pediatric Patients 3-69

4. INTRAOCULAR LENS (IOL) - TECHNOLOGY 4-1

4.1 The Human Eye 4-1 4.2 Cataracts 4-3 4.2.1 Staar Collamer 4-4 4.2.2 Cataract Symptoms 4-17 4.2.3 Benefits Of Cataract Eye Surgery 4-18 4.2.4 How Cataract Eye Surgery Is Performed 4-19 4.3 Intraocular Tens Technology 4-20 4.3.1 Technologies Driving Intraocular Lens IOL Market Growth 4-21 4.4 Aspheric Contact Lenses 4-21 4.5 Refractive Disorders 4-22 4.6 Studies On The Restor Toric Lens 4-22 4.6.1 MNRead Functional Reading Test 4-23 4.7 Surgeons Need To Concentrate On Proper Patient Selection 4-24 4.8 Mayo Clinic Study of Long-Term Dislocation Of Intraocular Lenses 4-24 4.8.1 Obesity Cause of Diabetes and Neuropathy of the Eye 4-25

5. INTRAOCULAR LENS (IOL) - COMPANY DESCRIPTION 5-1

5.1 Abbott Laboratories 5-1 5.1.1 Abbott Acquired Visiogen with Synchrony Product 5-1 5.1.2 Abbott Labs Cataract Company Acquisitions 5-2 5.1.3 Abbott Completes Separation of Research-Based Pharmaceuticals Business 5-3 5.1.4 Abbott (NYSE: ABT) Separation Of Its Research-Based Pharmaceuticals Business 5-3 5.1.5 Abbott Separating Into Two Independent Companies 5-4 5.1.6 Abbott Laboratories and Subsidiaries Revenue 5-4 5.1.7 Abbott Sales Mix 5-6 5.1.8 Abbott Nutritional Market Presence 5-7 5.1.9 Abbott Diagnostics Market Presence 5-8 5.1.10 Abbott Medical Devices Market Presence 5-8 5.1.11 Abbott Strength Through Ability to Innovate 5-9 5.1.12 Abbott Revenue 5-10 5.1.13 Abbott Medical Optics 5-11 5.1.14 Abbott Medical Optics Corneal Products 5-11 5.1.15 Abbott Medical Optics Refractive Product Line 5-12 5.1.16 Abbott Medical Optics Cataract Products 5-12 5.1.17 Abbott Medical Optics Technological Innovation 5-12 5.2 Akkolens 5-13 5.2.1 AkkoLens Features 5-14 5.2.2 AkkoLens Clinical Partners 5-15 5.3 Allergan 5-16 5.3.1 Allergan Flagship Franchises In Eye Care, Neurosciences, Medical Dermatology And Urologics 5-17 5.3.2 Allergan Acquisition of Inamed Corporation 5-17 5.3.3 Allergan Specialty Product Lines Focused On High-Growth Markets 5-17 5.3.4 Allergan Global in reach. Specialized in focus 5-18 5.3.5 Allergan Leading Products 5-19 5.3.6 Allergan/ SkinMedica, Inc. Acquisition 5-19 5.3.7 Allergan Obesity Intervention 5-19 5.4 Aravind 5-20 5.4.1 Future of Aravind 5-21 5.5 Bausch And Lomb 5-21 5.5.1 Bausch + Lomb Vision Care 5-21 5.5.2 Bausch + Lomb Pharmaceuticals 5-22 5.5.3 Bausch + Lomb Cataract and Vitreoretinal Surgery 5-22 5.5.4 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH 5-23 5.5.5 Bausch + Lomb Technolas Perfect Vision 5-24 5.5.6 Bausch + Lomb Technolas Perfect Vision Transforming Refractive Surgery 5-25 5.5.7 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH 5-25 5.5.8 Technolas Perfect Vision 5-26 5.6 Biovision 5-26 5.7 Elenza 5-27 5.8 Kowa Company, Ltd. 5-28 Environmental & Energy Saving Products 5-29 5.9 Hoya 5-33 5.9.1 Hoya, Seiko And Epson; Agreements Executed In The Field Of Optical Products Business 5-35 5.9.2 Hoya Second Quarter Revenue 5-36 5.10 Lenstec 5-38 5.11 Novartis Group / Alcon 5-39 5.11.1 Novartis Alcon Division 5-39 5.11.2 Novartis Revenue 5-40 5.11.3 Alcon Cataract Surgery 5-42 5.11.4 Alcon Surgical Glaucoma 5-42 5.11.5 Alcon Vitreoretinal 5-43 5.11.6 Alcon Refractive Surgery 5-43 5.11.7 Alcon Acquires Leading Ocular Surgical Guidance Technology 5-43

5.11.8 Alcon 5-44

5.11.9 Alcon Acquired The Ophthalmic Division of SensoMotoric Instruments (SMI) 5-49

5.11.10 Alcon Division Surgical Products 5-49

5.11.11 Alcon Ophthalmic Pharmaceuticals 5-50

5.11.12 Alcon Products 5-51

5.11.13 Alcon Cataract Reimbursement 5-52

5.11.14 Alcon Regulation 5-53

5.11.15 LenSx Acquired by Alcon 5-54

5.12 OptiMedica 5-54

5.12.1 Catalys next generation laser cataract surgery platform 5-56

5.13 Physiol 5-56

5.13.1 Physiol Multifocal IOL FineVision (Micro F) 2 5-57

5.14 Rayner 5-57

5.14.1 Surgery on 109 Year old Woman Using Rayner IOL 5-58

5.15 Staar Surgical 5-58

5.15.1 STAAR Surgical Devices Used In Corrective Surgery 5-59

5.15.2 STAAR Surgical Minimally Invasive Intraocular Lenses (IOLs). 5-65

5.16 WaveTec Vision 5-67

5.16.1 WaveTec Vision Secures $16.5m To Market

Cataract Surgery System 5-67

5.17 Zeiss – 5-68

5.17.1 Zeiss Vision 5-69

5.17.2 Zeiss Revenue 5-69

5.18 Selected Companies in the Market 5-70

List of Tables and Figures

Table ES-1 ES-1 Intraocular Lens Market Driving Forces Figure ES-2 ES-2 Advanced Technology Intraocular Lens Growth Drivers Table ES-2 ES-4 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift. Table ES-3 ES-6 Intraocular Lens Market Challenges Table ES-4 ES-8 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide, 2012 Figure ES-5 ES-9 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019

Intraocular Lens - Market Description and Market Dynamics

Table 1-1 1-3 Cataract Surgery Diverse Market Growth Drivers Table 1-2 1-6 Intraocular Lens Market Challenges Table 2-1 2-1 Intraocular Lens Market Driving Forces Figure 2-2 2-2 Advanced Technology Intraocular Lens Growth Drivers Table 2-2 2-4 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift Table 2-3 2-6 Intraocular Lens Market Challenges Table 2-4 2-8 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide, 2012 Table 2-5 2-9 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide, 2012 Table 2-6 2-11 Novartis Cataract Surgical Techniques Figure 2-7 2-12 Novartis / Alcon Overview of Surgical Franchise Figure 2-8 2-15 Alcon Key Intraocular Lenses (IOLs) Products Table 2-9 2-16 Novartis / Alcon IOL Market Strategic Positioning Figure 2-10 2-21 Bausch + Lomb Crystalens is an FDA-approved intraocular lens Table 2-11 2-27 ReSTOR's Acrylic Material Helps Keep It From Rotating Postop Figure 2-12 2-29 Abbott Tecnis Toric IOL Figure 2-13 2-30 Lenstec Tetraflex Figure 2-14 2-31 Abbott Visiogen Synchrony Figure 2-15 2-33 NuLens DynaCurv Figure 2-16 2-35 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019 Table 2-17 2-36 Intraocular Lens Market Forecasts Units and Dollars, Worldwide, 2013-2019 Figure 2-18 2-37 Low End Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019 Figure 2-19 2-38 Premium Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019 Table 2-20 2-39 Intraocular Lens (IOL) Market Forecasts Units and Dollars, Worldwide, 2013-2019 Figure 2-21 2-41 Intraocular Lens (IOL), Market Forecasts, Units, Worldwide, 2013-2019 Figure 2-22 2-43 Novartis Franchise Dedicated Resources Figure 2-23 2-45

Cataract Surgery Pathophysiology, Prevalence, and Surgical Techniques

Table 2-24 2-47

Intraocular Lens Description

Table 2-25 2-48

Intraocular Lens Advanced Technology

Figure 2-26 2-53

Novartis Commentary on Cataracts as Leading Cause of

Reversible Blindness

Figure 2-27 2-59

Intraocular Lens (IOL) Regional Market Segments, Dollars, 2012

Table 2-28 2-60

Intraocular Lens (IOL) Regional Market Revenue Segments,

US and Worldwide, Dollars, Worldwide, 2013-2019

Table 2-29 2-61

Intraocular Lens (IOL) Regional Market Revenue Segments,

US and Worldwide Percent, Worldwide, 2013-2019

Figure 2-30 2-63

Eye Surgical Techniques by Country

Intraocular Lens - Product Description

Novartis / Alcon Key Intraocular Lenses (IOLs) Products

Table 3-2 3-4

Novartis Cataract Surgical Techniques

Figure 3-3 3-5

Novartis / Alcon Overview of Surgical Franchise

Table 3-4 3-8

Novartis / Alcon IOL Market Strategic Positioning

Table 3-5 3-10

Abbott Medical Optics Cataract Products

Table 3-6 3-14

Abbott Medical Visiogen's Synchrony lens Advantages

Table 3-7 3-15

Abbott Medical Visiogen's Synchrony Lens Disadvantages

Figure 3-8 3-19

Bausch + Lomb Crystalens FDA-Approved Intraocular Lens

Figure 3-9 3-20

Bausch + Lomb: Crystalens IOL Features

Figure 3-10 3-27

STAAR Surgical Company nanoFLEX IOL

Figure 3-11 3-28

Staar Implantable Collamer Lens for Quality of Vision

Table 3-12 3-30

Staar IOL Products

Figure 3-12 3-50

Staar Toric Visual Acuity

Figure 3-13 3-61

Hoya Pre-Loaded IOL Delivery System "iSert

Figure 4-1 4-2

Human Eye

Figure 4-2 4-5

Staar nanoFLEX

Figure 4-3 4-6

Staar nanoFLEX Collamer has a built in Anti-Reflective Interface

Figure 4-4 4-8

Staar Hydrophilic Collamer Ultra-High Water Content Layer

On Its Surface Minimizing The Difference In Refractive Index

Figure 4-5 4-9

Staar nanoFLEX Collamer Percentage of Light Reflectance

Figure 4-6 4-10

Staar nanoFLEX Collamer Single Piece IOL

Figure 4-7 4-11

Staar nanoFLEX Collamer Incision Size

Figure 4-8 4-12

Staar nanoFLEX Collamer Protective Layer

Figure 4-9 4-13

Staar Afinity 3-Piece Collamer Aspheric IOL Model CQ2015A

Function 4-10 4-14

Modulation Transfer Function (MTF) Analysis

Table 4-11 4-17

Cataract Symptoms

Intraocular Lens - Company Profiles

AkkoLens Technological Features

Table 5-2 5-15

AkkoLens Medical Features

Figure 5-3 5-34

Hoya IOL plant in Singapore

Figure 5-4 5-46

Novartis / Alcon Positioning in Healthcare

Figure 5-5 5-47

Novartis Resource By Segment

Figure 5-6 5-48

Novartis Surgical Franchise

To order this report:Ophthalmic_Devices Industry: Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED